Company / Current Liabilities per Share
Cartesian Therapeutics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.58
FY2025
5-year range
$0.20 / $4.26
FY2021-FY2025
Trend
-86.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $0.45 to $0.58 over the past 2 years.
Based on SEC 10-K filings.
0.58 in FY2025 with a 5-year CAGR of -9.3%.
Increased from $0.45 to $0.58 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +41.9%
- 5-Year CAGR
- -9.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 86.4% year-over-year.
- Peak current liabilities per share was recorded in FY2016.
- Lowest current liabilities per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.58 | -86.4% |
| FY2024 | $4.26 | +855.1% |
| FY2023 | $0.45 | +119.7% |
| FY2022 | $0.20 | -69.7% |
| FY2021 | $0.67 | -29.2% |
| FY2020 | $0.94 | -39.3% |
| FY2019 | $1.55 | -75.3% |
| FY2016 | $6.31 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026